Direxion Daily Semiconductor Bull 3x Shares ETF
SOXL
VanEck Semiconductor ETF
SMH
The Technology Select Sector SPDR® Fund
XLK
4
Invesco Solar ETF
TAN
5
Invesco DB Commodity Index Tracking Fund
DBC
US Stock MarketDetailed Quotes
Nexalin Technology (NXL)
- 0.3424
- +0.0023+0.68%
Close May 12 16:00 ET
- 0.3423
- -0.0001-0.03%
Post 19:06 ET
7.05MMarket Cap-0.74P/E (TTM)
0.3499High0.3400Low54.21KVolume0.3400Open0.3401Prev Close18.70KTurnover0.30%Turnover RatioLossP/E (Static)20.58MShares2.000052wk High2.45P/B6.12MFloat Cap0.330252wk Low--Dividend TTM17.86MShs Float4.4899Historical High--Div Yield TTM2.91%Range %0.2528Historical Low0.3449Avg Price1Lot Size
NXL Stock Chart
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
NXL Orderflow
Unit: --
NXL Orderflow Trend
IntradayDayWeekMonth
No Data
Nexalin Technology (NXL) News
Nexalin Technology | 10-Q: Q1 2026 Earnings Report
12 Health Care Stocks Moving In Tuesday's After-Market Session
Nexalin Announces Publication Of Peer-Reviewed Study In Psychotherapy And Psychosomatics Reporting Clinical Improvement In Chronic Insomnia Patients Using Nexalin's High-Power 15 MA, 77.5Hz Stimulation Approach
Nexalin Advances Pivotal Insomnia Trial for HALO Clarity
Nexalin To Begin Enrollment For Pivotal HALO Clarity Insomnia Trial In Q2 2026; Targeting FDA De Novo Pathway
RedChip's Biotech Investor Conference Replays Now Available
Nexalin Technology (NXL) Stock Forum
$Nexalin Technology (NXL.US)$
Nexalin Announces Peer-Reviewed Publication with Neuroimaging Data in Psychotherapy and Psychosomatics Highlighting Brain-Network Effects and Clinical Improvement in Chronic Insomnia
by Globe Newswire
Follow
Publication reports statistically significant improvement in sleep quality following treatment with Nexalin's 15 mA, 77.5 Hz stimulation approach, with no meaningful improvement in the sham group
Neuroimaging data provides mechanistic support for Nexalin...
Nexalin Announces Peer-Reviewed Publication with Neuroimaging Data in Psychotherapy and Psychosomatics Highlighting Brain-Network Effects and Clinical Improvement in Chronic Insomnia
by Globe Newswire
Follow
Publication reports statistically significant improvement in sleep quality following treatment with Nexalin's 15 mA, 77.5 Hz stimulation approach, with no meaningful improvement in the sham group
Neuroimaging data provides mechanistic support for Nexalin...
$Nexalin Technology (NXL.US)$ why has moomoo be restricting small cap trades?
1
1
$Nexalin Technology (NXL.US)$ solid news over $0.49
Nexalin Announces Peer-Reviewed Study Showing the Company's DIFS Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents
Nexalin Announces Peer-Reviewed Study Showing the Company's DIFS Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents
2
$Nexalin Technology (NXL.US)$ EXCLUSIVE: Nexalin Study Flags Reduced Self-Injury In Adolescents Using Brain Stimulation Device
Benzinga
3m
Nexalin Technology, Inc. (NASDAQ:NXL) on Thursday announced another publication of a peer-reviewed study in BMC Psychiatry related to the company's Deep Intracranial Frequency Stimulation (DIFS) technology.
Data Shows Reduction In Self-Injury And Depressive Symptoms
The data reported that Nexalin's DIFS 77.5 Hz high-gamma approach was associated with sta...
Benzinga
3m
Nexalin Technology, Inc. (NASDAQ:NXL) on Thursday announced another publication of a peer-reviewed study in BMC Psychiatry related to the company's Deep Intracranial Frequency Stimulation (DIFS) technology.
Data Shows Reduction In Self-Injury And Depressive Symptoms
The data reported that Nexalin's DIFS 77.5 Hz high-gamma approach was associated with sta...
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)